Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of Lantus basal insulin administration in type 2 diabetes
2005-002958-21Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sanofi. Primary endpoint: HbA1c at end of each treatment period. Started Jul 2005; status: terminated.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-002958-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002958-21.